HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury.

Abstract
Nitric oxide (NO) is an important regulator of vascular and myocardial function. Cardiac ischemia/reperfusion injury is reduced in mice overexpressing endothelial NO synthase (eNOS) suggesting cardioprotection by eNOS. Novel pharmacological substances, so called eNOS enhancers, upregulate eNOS expression and thereby increase NO production. We tested the effects of the eNOS enhancer AVE 9488 on cardiac ischemia/reperfusion injury in vivo in mice. After treatment with the eNOS enhancer AVE 9488 (30 mg/kg/day) or placebo for one week mice underwent 30 min of coronary artery ligation and 24 h of reperfusion in vivo. Ischemia-reperfusion damage was significantly reduced in mice treated with the eNOS enhancer when compared to placebo treated mice (infarct/area at risk 65.4 +/- 4.1 vs. 36.9 +/- 4.0%, placebo vs. eNOS enhancer, P = 0.0002). The protective effect was blunted in eNOS knockout mice treated with the eNOS enhancer (infarct/area at risk 64.1 +/- 6.2%, eNOS knockout + eNOS enhancer vs. WT + eNOS enhancer, P = ns). Reactive oxygen species were significantly reduced in mice treated with the eNOS enhancer as indicated by significantly lower malondialdehyde-thiobarbituric acid levels (placebo vs. eNOS enhancer, 3.2 +/- 0.5 vs. 0.8 +/- 0.07 micromol/l, P = 0.0003). Thus pharmacological interventions addressed to increase eNOS-derived NO production constitute a promising therapeutic approach to prevent myocardial ischemia/reperfusion injury.
AuthorsS Frantz, A Adamek, D Fraccarollo, J Tillmanns, J D Widder, C Dienesch, A Schäfer, A Podolskaya, M Held, H Ruetten, G Ertl, J Bauersachs
JournalBasic research in cardiology (Basic Res Cardiol) Vol. 104 Issue 6 Pg. 773-9 (Nov 2009) ISSN: 1435-1803 [Electronic] Germany
PMID19548059 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 4-fluoro-N-indan-2-yl-benzamide
  • Benzamides
  • Cell Adhesion Molecules
  • Microfilament Proteins
  • Phosphoproteins
  • vasodilator-stimulated phosphoprotein
  • Nitric Oxide Synthase Type III
Topics
  • Animals
  • Benzamides (pharmacology)
  • Cell Adhesion Molecules (metabolism)
  • Female
  • Hemodynamics (drug effects)
  • Immunohistochemistry
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microfilament Proteins (metabolism)
  • Myocardial Reperfusion Injury (pathology, prevention & control)
  • Nitric Oxide Synthase Type III (drug effects, metabolism)
  • Oxidative Stress (drug effects)
  • Phosphoproteins (metabolism)
  • Phosphorylation
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: